These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2243136)

  • 21. Differential sensitization by orobol in proliferating and quiescent human ovarian carcinoma cells.
    Shiotsuka S; Isonishi S
    Int J Oncol; 2001 Feb; 18(2):337-42. PubMed ID: 11172601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro.
    Jekunen A; Vick J; Sanga R; Chan TC; Howell SB
    Cancer Res; 1992 Jul; 52(13):3566-71. PubMed ID: 1617625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversing chemoresistance in cisplatin-resistant human ovarian cancer cells: a role of c-Jun NH2-terminal kinase 1.
    Li F; Meng L; Zhou J; Xing H; Wang S; Xu G; Zhu H; Wang B; Chen G; Lu YP; Ma D
    Biochem Biophys Res Commun; 2005 Oct; 335(4):1070-7. PubMed ID: 16105650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
    Alper O; Hacker NF; Cho-Chung YS
    Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
    Andrews PA; Velury S; Mann SC; Howell SB
    Cancer Res; 1988 Jan; 48(1):68-73. PubMed ID: 3335000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic effects of epidermal growth factor and hepatocyte growth factor on human ovarian cancer cell invasion and migration: role of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.
    Zhou HY; Pon YL; Wong AS
    Endocrinology; 2007 Nov; 148(11):5195-208. PubMed ID: 17673518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of functional epidermal growth factor receptors in a human hematopoietic cell line.
    Oval J; Hershberg R; Gansbacher B; Gilboa E; Schlessinger J; Taetle R
    Cancer Res; 1991 Jan; 51(1):150-6. PubMed ID: 1703031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
    Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
    Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin reduces epidermal growth factor receptors in squamous-cell carcinoma in vitro. Preliminary results.
    Bergler W; Bier H
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(5):297-302. PubMed ID: 2234901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of hREV1 expression reduces the rate at which human ovarian carcinoma cells acquire resistance to cisplatin.
    Okuda T; Lin X; Trang J; Howell SB
    Mol Pharmacol; 2005 Jun; 67(6):1852-60. PubMed ID: 15758147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Establishment of human ovarian cancer cisplatin resistant cell line COC1/DDP and its mechanism of resistance].
    Zhou Y; Chen H; Yang Q
    Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):680-3. PubMed ID: 9275551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells.
    Levasseur LM; Greco WR; Rustum YM; Slocum HK
    Cancer Chemother Pharmacol; 1997; 40(6):495-505. PubMed ID: 9332464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells.
    Theodorescu D; Cornil I; Sheehan C; Man MS; Kerbel RS
    Cancer Res; 1991 Aug; 51(16):4486-91. PubMed ID: 1868471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of tamoxifen, methoxyprogesterone acetate and combined treatment on cellular proliferation and apoptosis in SKOV3/DDP cells via the regulation of vascular endothelial growth factor.
    Wen L; Hong D; Yanyin W; Mingyue Z; Baohua L
    Arch Gynecol Obstet; 2013 May; 287(5):997-1004. PubMed ID: 23212665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation.
    Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Kouttab N; Chu W; Wan Y
    Int J Oncol; 2006 Oct; 29(4):1003-11. PubMed ID: 16964397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single step selection of cis-diamminedichloroplatinum(II) resistant mutants from a human ovarian carcinoma cell line.
    McLaughlin K; Stephens I; McMahon N; Brown R
    Cancer Res; 1991 Apr; 51(8):2242-5. PubMed ID: 1901242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.